论文部分内容阅读
尿激酶(Urokinase)是一种溶解血栓的药物。我科应用国产尿激酶(是从男尿提得的一种能激活纤溶酶原的蛋白酶制剂)治疗40例脑血栓形成,现报告于下。一、病例情况:本组40例中,男22例,女18例。年龄最小42岁,最大78岁。从起病至开始接受治疗,最短3小时,最长7天。40例都有不同程度的中枢性偏瘫,其中肌力在3级以下者29例,绝大多数有锥体束征。35例伴有中枢性面瘫和舌下神经瘫。12例有运动性失语。1例有命名性失语。2例有混合性失语。6例伴有半身感觉障碍。本组病例的诊断,主要根据高血压动脉
Urokinase is a thrombolytic drug. 40 cases of cerebral thrombosis were treated with domestic urokinase (a kind of protease preparation that can be activated from plasminogen obtained from male urine), which is reported below. First, the case: 40 cases in this group, 22 males and 18 females. The youngest 42 years old, the largest 78 years old. From the onset to the beginning of treatment, the shortest 3 hours, up to 7 days. There are 40 cases of central hemiplegia to varying degrees, of which muscle strength in the following 29 cases, the vast majority of pyramidal tract signs. 35 cases with central facial paralysis and hypoglossal nerve paralysis. 12 cases of exercise aphasia. 1 case of nominal aphasia. 2 cases had mixed aphasia. 6 cases with hemiplegia. The diagnosis of this group of patients, mainly based on hypertension arteries